The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Drug Monitoring (TDM) Service Market Research Report 2025
Synopsis
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The global Therapeutic Drug Monitoring (TDM) Service market was valued at US$ 1804.3 million in 2023 and is anticipated to reach US$ 2292.9 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring (TDM) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring (TDM) Service.
Report Scope
The Therapeutic Drug Monitoring (TDM) Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Drug Monitoring (TDM) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring (TDM) Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring (TDM) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The global Therapeutic Drug Monitoring (TDM) Service market was valued at US$ 1804.3 million in 2023 and is anticipated to reach US$ 2292.9 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring (TDM) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring (TDM) Service.
Report Scope
The Therapeutic Drug Monitoring (TDM) Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Drug Monitoring (TDM) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring (TDM) Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring (TDM) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring (TDM) Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Labs
1.3.3 Independent Clinical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Perspective (2019-2030)
2.2 Therapeutic Drug Monitoring (TDM) Service Growth Trends by Region
2.2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Region (2019-2024)
2.2.3 Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Region (2025-2030)
2.3 Therapeutic Drug Monitoring (TDM) Service Market Dynamics
2.3.1 Therapeutic Drug Monitoring (TDM) Service Industry Trends
2.3.2 Therapeutic Drug Monitoring (TDM) Service Market Drivers
2.3.3 Therapeutic Drug Monitoring (TDM) Service Market Challenges
2.3.4 Therapeutic Drug Monitoring (TDM) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring (TDM) Service Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring (TDM) Service Players by Revenue (2019-2024)
3.1.2 Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Players (2019-2024)
3.2 Global Therapeutic Drug Monitoring (TDM) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Drug Monitoring (TDM) Service Revenue
3.4 Global Therapeutic Drug Monitoring (TDM) Service Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring (TDM) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring (TDM) Service Revenue in 2023
3.5 Therapeutic Drug Monitoring (TDM) Service Key Players Head office and Area Served
3.6 Key Players Therapeutic Drug Monitoring (TDM) Service Product Solution and Service
3.7 Date of Enter into Therapeutic Drug Monitoring (TDM) Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring (TDM) Service Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Type (2019-2024)
4.2 Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Type (2025-2030)
5 Therapeutic Drug Monitoring (TDM) Service Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Application (2019-2024)
5.2 Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Therapeutic Drug Monitoring (TDM) Service Market Size (2019-2030)
6.2 North America Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024)
6.4 North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Drug Monitoring (TDM) Service Market Size (2019-2030)
7.2 Europe Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024)
7.4 Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size (2019-2030)
8.2 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size (2019-2030)
9.2 Latin America Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024)
9.4 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size (2019-2030)
10.2 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring (TDM) Service Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring (TDM) Service Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring (TDM) Service Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring (TDM) Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Therapeutic Drug Monitoring (TDM) Service Introduction
11.5.4 Siemens Healthineers Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.5.5 Siemens Healthineers Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Detail
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Therapeutic Drug Monitoring (TDM) Service Introduction
11.7.4 bioMerieux Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.7.5 bioMerieux Recent Development
11.8 Bühlmann Laboratories
11.8.1 Bühlmann Laboratories Company Detail
11.8.2 Bühlmann Laboratories Business Overview
11.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.8.4 Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.8.5 Bühlmann Laboratories Recent Development
11.9 Randox Laboratories
11.9.1 Randox Laboratories Company Detail
11.9.2 Randox Laboratories Business Overview
11.9.3 Randox Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.9.4 Randox Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.9.5 Randox Laboratories Recent Development
11.10 Sekisui Medical
11.10.1 Sekisui Medical Company Detail
11.10.2 Sekisui Medical Business Overview
11.10.3 Sekisui Medical Therapeutic Drug Monitoring (TDM) Service Introduction
11.10.4 Sekisui Medical Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
11.10.5 Sekisui Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Key Players of Saliva Test
Table 5. Global Therapeutic Drug Monitoring (TDM) Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Therapeutic Drug Monitoring (TDM) Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Region (2019-2024)
Table 9. Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Region (2025-2030)
Table 11. Therapeutic Drug Monitoring (TDM) Service Market Trends
Table 12. Therapeutic Drug Monitoring (TDM) Service Market Drivers
Table 13. Therapeutic Drug Monitoring (TDM) Service Market Challenges
Table 14. Therapeutic Drug Monitoring (TDM) Service Market Restraints
Table 15. Global Therapeutic Drug Monitoring (TDM) Service Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Players (2019-2024)
Table 17. Global Top Therapeutic Drug Monitoring (TDM) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring (TDM) Service as of 2023)
Table 18. Ranking of Global Top Therapeutic Drug Monitoring (TDM) Service Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Therapeutic Drug Monitoring (TDM) Service Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Therapeutic Drug Monitoring (TDM) Service Product Solution and Service
Table 22. Date of Enter into Therapeutic Drug Monitoring (TDM) Service Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Therapeutic Drug Monitoring (TDM) Service Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Type (2019-2024)
Table 26. Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Type (2025-2030)
Table 28. Global Therapeutic Drug Monitoring (TDM) Service Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Application (2019-2024)
Table 30. Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Application (2025-2030)
Table 32. North America Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Therapeutic Drug Monitoring (TDM) Service Product
Table 50. Roche Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Danaher Company Detail
Table 53. Danaher Business Overview
Table 54. Danaher Therapeutic Drug Monitoring (TDM) Service Product
Table 55. Danaher Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 56. Danaher Recent Development
Table 57. Abbott Company Detail
Table 58. Abbott Business Overview
Table 59. Abbott Therapeutic Drug Monitoring (TDM) Service Product
Table 60. Abbott Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. Thermo Fisher Scientific Company Detail
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Therapeutic Drug Monitoring (TDM) Service Product
Table 65. Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Siemens Healthineers Company Detail
Table 68. Siemens Healthineers Business Overview
Table 69. Siemens Healthineers Therapeutic Drug Monitoring (TDM) Service Product
Table 70. Siemens Healthineers Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 71. Siemens Healthineers Recent Development
Table 72. Bio-Rad Laboratories Company Detail
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Therapeutic Drug Monitoring (TDM) Service Product
Table 75. Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. bioMerieux Company Detail
Table 78. bioMerieux Business Overview
Table 79. bioMerieux Therapeutic Drug Monitoring (TDM) Service Product
Table 80. bioMerieux Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 81. bioMerieux Recent Development
Table 82. Bühlmann Laboratories Company Detail
Table 83. Bühlmann Laboratories Business Overview
Table 84. Bühlmann Laboratories Therapeutic Drug Monitoring (TDM) Service Product
Table 85. Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 86. Bühlmann Laboratories Recent Development
Table 87. Randox Laboratories Company Detail
Table 88. Randox Laboratories Business Overview
Table 89. Randox Laboratories Therapeutic Drug Monitoring (TDM) Service Product
Table 90. Randox Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 91. Randox Laboratories Recent Development
Table 92. Sekisui Medical Company Detail
Table 93. Sekisui Medical Business Overview
Table 94. Sekisui Medical Therapeutic Drug Monitoring (TDM) Service Product
Table 95. Sekisui Medical Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024) & (US$ Million)
Table 96. Sekisui Medical Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Drug Monitoring (TDM) Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Type: 2023 VS 2030
Figure 3. Blood Test Features
Figure 4. Urine Test Features
Figure 5. Saliva Test Features
Figure 6. Global Therapeutic Drug Monitoring (TDM) Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Application: 2023 VS 2030
Figure 8. Hospital Labs Case Studies
Figure 9. Independent Clinical Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Therapeutic Drug Monitoring (TDM) Service Report Years Considered
Figure 12. Global Therapeutic Drug Monitoring (TDM) Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Therapeutic Drug Monitoring (TDM) Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Region: 2023 VS 2030
Figure 15. Global Therapeutic Drug Monitoring (TDM) Service Market Share by Players in 2023
Figure 16. Global Top Therapeutic Drug Monitoring (TDM) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring (TDM) Service as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Therapeutic Drug Monitoring (TDM) Service Revenue in 2023
Figure 18. North America Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Therapeutic Drug Monitoring (TDM) Service Market Share by Country (2019-2030)
Figure 20. United States Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Therapeutic Drug Monitoring (TDM) Service Market Share by Country (2019-2030)
Figure 24. Germany Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Share by Region (2019-2030)
Figure 32. China Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Therapeutic Drug Monitoring (TDM) Service Market Share by Country (2019-2030)
Figure 40. Mexico Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Share by Country (2019-2030)
Figure 44. Turkey Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Therapeutic Drug Monitoring (TDM) Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 47. Danaher Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 50. Siemens Healthineers Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 52. bioMerieux Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 53. Bühlmann Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 54. Randox Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 55. Sekisui Medical Revenue Growth Rate in Therapeutic Drug Monitoring (TDM) Service Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
